CRIS Current Research Information System

BIFFI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.384
AS - Asia 10.724
EU - Europa 9.393
AF - Africa 597
SA - Sud America 588
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 6
Totale 33.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.269
VN - Vietnam 3.569
SG - Singapore 2.784
GB - Regno Unito 2.438
CN - Cina 2.308
IT - Italia 1.948
DE - Germania 1.251
UA - Ucraina 819
HK - Hong Kong 723
FR - Francia 697
SE - Svezia 607
RU - Federazione Russa 536
IN - India 529
BR - Brasile 416
IE - Irlanda 293
EE - Estonia 215
JP - Giappone 194
CI - Costa d'Avorio 180
ZA - Sudafrica 179
NL - Olanda 176
FI - Finlandia 145
BD - Bangladesh 112
KR - Corea 95
TG - Togo 83
SC - Seychelles 77
AR - Argentina 75
PH - Filippine 62
CA - Canada 59
BG - Bulgaria 46
JO - Giordania 45
CH - Svizzera 39
IQ - Iraq 39
TH - Thailandia 39
MX - Messico 33
IR - Iran 31
AT - Austria 30
ID - Indonesia 28
NG - Nigeria 28
BE - Belgio 26
TW - Taiwan 26
PL - Polonia 24
CL - Cile 23
TR - Turchia 23
PK - Pakistan 21
CO - Colombia 20
EC - Ecuador 20
SA - Arabia Saudita 20
ES - Italia 17
UZ - Uzbekistan 16
AU - Australia 15
EG - Egitto 15
GR - Grecia 15
PY - Paraguay 13
RO - Romania 13
MY - Malesia 10
CZ - Repubblica Ceca 9
LB - Libano 9
UY - Uruguay 9
LT - Lituania 8
MA - Marocco 8
NP - Nepal 7
DZ - Algeria 6
HR - Croazia 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
OM - Oman 5
PE - Perù 5
SN - Senegal 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
LU - Lussemburgo 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
DK - Danimarca 3
IL - Israele 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
GP - Guadalupe 2
HN - Honduras 2
KG - Kirghizistan 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
BZ - Belize 1
Totale 33.694
Salva come PNG Salva come JPEG
Città #
Southend 2.147
Singapore 1.902
Ashburn 1.260
Fairfield 1.166
San Jose 884
Ho Chi Minh City 734
Hong Kong 680
Chandler 661
Jacksonville 586
Wilmington 581
Hanoi 554
Woodbridge 530
Seattle 515
Santa Clara 514
Princeton 512
Houston 511
Dong Ket 457
Cambridge 419
Ann Arbor 318
Boardman 296
Dublin 292
Beijing 282
Lauterbourg 246
Padova 233
Westminster 232
Nanjing 215
Los Angeles 206
Council Bluffs 202
Abidjan 180
Tokyo 180
Milan 163
Hefei 157
Berlin 144
Helsinki 133
Shenyang 123
New York 122
Saint Petersburg 122
Medford 116
Buffalo 109
Jinan 107
Rome 107
Bologna 98
Changsha 89
Mülheim 88
San Diego 88
Da Nang 84
Lomé 83
Bremen 73
Haiphong 72
Mahé 72
Turin 70
Hebei 69
Dallas 65
Frankfurt am Main 64
Nanchang 63
Redondo Beach 57
São Paulo 57
Seoul 56
Guangzhou 55
Jiaxing 53
Des Moines 52
Zhengzhou 48
Tianjin 47
Munich 46
Olalla 44
Sofia 44
Amman 42
Shanghai 41
Chicago 40
The Dalles 39
Yubileyny 38
Hangzhou 37
Naples 37
Ningbo 36
Biên Hòa 35
Hải Dương 34
Verona 31
Bari 30
Phoenix 30
Dearborn 27
Taizhou 27
Abeokuta 26
Brussels 26
Norwalk 26
Falkenstein 25
Falls Church 25
Can Tho 24
Haikou 24
Mountain View 24
Ninh Bình 24
Lanzhou 23
Toronto 23
Brooklyn 22
London 22
San Francisco 22
Thái Nguyên 22
Florence 21
Johannesburg 21
Quận Bình Thạnh 21
Bắc Giang 20
Totale 21.500
Salva come PNG Salva come JPEG
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.117
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 330
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 290
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 264
Resynchronization for HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) Investigators. A prospective randomized evaluation of VV delay optimization in CRT-D recipients:echocardiographic observations from the RHYTHM II ICD study. 262
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 250
Atrial fibrillation: it is better to be alone than in bad company! 230
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 229
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 223
AF burden is important - Fact or fiction? 218
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 217
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 209
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 207
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 207
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 205
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 201
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 200
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 199
Automatic verification of ventricular stimulation: fusion management algorithm 198
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 198
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 197
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 196
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 195
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 194
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 193
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 192
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 186
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 186
Atrial fibrillation ablation: beyond electro-mechanical matters 184
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 183
Automatic management of left ventricular stimulation: hints for technologic improvement. 183
Implantation of cardioverter-defibrillator: Effects on shoulder function. 180
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 179
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 178
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 177
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 176
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 176
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections 176
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 175
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 175
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 174
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 173
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 173
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 172
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 171
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 171
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 170
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 170
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 170
Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. 169
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 169
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 169
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 169
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 167
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 167
Predictors of long-term survival free from relapses after extraction of infected CIED. 166
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 166
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 165
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 165
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 164
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 161
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 159
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 158
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 158
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 158
Atrial fibrillation and heart failure: does one epidemic feed he other? 157
Cardiac resynchronization therapy: is systole all that matters? 156
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 153
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 153
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 153
The QRS interval in patients treated with resynchronization therapy: which value 152
Phrenic stimulation: a challenge for cardiac resynchronization therapy 152
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 152
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 151
Less is more: Can we achieve cardiac resynchronization with 2 leads only? 149
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 149
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 148
Follow-up a lungo termine di pazienti con sincope valutati con tilt test 146
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 146
Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. 146
Ventricular dyssynchrony at rest and during exercise assessed by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 145
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 145
Is cardiac resynchronization therapy cost-effective? 145
Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a 'real world' regional registry. 145
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 145
Single versus dual-chamber ICDs : evaluation of rhythm discrimination QRS morphology. 144
Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. 143
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 143
A plateau waveform shape allows a much higher patient shock energy tolerance 142
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 141
Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure. 141
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 141
Long-term follow-up of patients with syncope evaluated by head-up tilt test. 141
Role of drugs and devices in patients at risk of sudden cardiac death. 141
Automatic verification of ventricular stimulation: fusion management algorithm 141
Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent 140
Cardiac resynchronization therapy: Implant rates, temporal trends and relationships with heart failure epidemiology 140
Cardioversione elettrica di fibrillazione atriale associata ad impianto di dispositivo per la resincronizzazione cardiaca: quali i risulatati a lungo termine? 139
Il follow up di pace maker e defibrillatori: Valutazione degli attuali disagi per i pazienti e del potenziale impatto di sistemi di controllo remoto mediante telemedicina. Abstract 69° Congresso Nazionale Società Italiana di Cardiologia 139
Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. 139
Totale 18.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.364 0 0 0 0 0 0 0 0 0 0 0 1.364
2021/20223.655 340 192 257 282 352 256 67 285 109 139 613 763
2022/20233.778 405 475 208 492 196 241 108 209 666 194 332 252
2023/20241.084 88 176 75 75 118 189 78 60 64 61 41 59
2024/20254.289 177 923 320 335 812 206 192 105 55 232 120 812
2025/20269.797 1.105 749 935 593 1.004 588 1.027 715 1.687 709 340 345
Totale 34.162